| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―17 |
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient |
Hanno Schmidt, Lea Schick, Jürgen Podlech, Angélique Renzaho, Bettina Lieb, Stefan Diederich, Thomas Hankeln, Bodo Plachter, Oliver Kriege |
| 2 |
[GO] |
2022―Sep―05 |
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility |
Georgios Voloudakis, James M. Vicari, Sanan Venkatesh, Gabriel E. Hoffman, Kristina Dobrindt, Wen Zhang, Noam D. Beckmann, Christina A. Higgins, Stathis Argyriou, Shan Jiang, Daisy Hoagland, Lina Gao, André Corvelo, Kelly Cho, Kyung Min Lee, Jiantao Bian, Jennifer S. Lee, Sudha K. Iyengar, Shiuh-Wen Luoh, Schahram Akbarian, Robert Striker, Themistocles L. Assimes, Eric E. Schadt, Julie A. Lynch, Miriam Merad, Benjamin R. tenOever, Alexander W. Charney, Kristen J. Brennand, John F. Fullard, Panos Roussos |
| 3 |
[GO] |
2022―Mar―22 |
Integrative transcriptomic, evolutionary, and causal inference framework for region-level analysis: Application to COVID-19 |
Dan Zhou, Eric R. Gamazon |
| 4 |
[GO] |
2021―Jul―01 |
TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19 |
Axel Schmidt, Sophia Peters, Alexej Knaus, Hemmen Sabir, Frauke Hamsen, Carlo Maj, Julia Fazaal, Sugirthan Sivalingam, Oleksandr Savchenko, Aakash Mantri, Dirk Holzinger, Ulrich Neudorf, Andreas Müller, Kerstin U. Ludwig, Peter M. Krawitz, Hartmut Engels, Markus M. Nöthen, Soyhan Bagci |
| 5 |
[GO] |
2021―May―10 |
Ethically utilising COVID-19 host-genomic data |
Christopher Gyngell, John Christodoulou, Julian Savulescu |
| 6 |
[GO] |
2020―Aug―18 |
Pharmacogenomics of COVID-19 therapies |
Takuto Takahashi, Jasmine A. Luzum, Melanie R. Nicol, Pamala A. Jacobson |
|
